Position in NPCE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,590,070
+$1,761,620 QoQ
Shares Held
163,000
+158.7% QoQ
Ownership
0.475%
of shares outstanding
% of Portfolio
2.43%
of 13F equity value
Holder Rank
#23
of 112 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NPCE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026HighMark Wealth Management LLC holds $30,374,309 across 26 Medical Devices names. NPCE ranks #4 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXGN |
Axogen, Inc.
|
341,390 | $15,768,804 | |
| 2 | SIBN |
SI-BONE, Inc.
|
425,049 | $6,936,799 | |
| 3 | MASS |
908 Devices Inc.
|
339,783 | $2,956,112 | |
| 4 | NPCE |
NeuroPace Inc
This page
|
163,000 | $2,590,070 | |
| 5 | TNDM |
Tandem Diabetes Care Inc
|
34,120 | $514,870 | |
| 6 | ATEC |
Alphatec Holdings, Inc.
|
52,900 | $457,585 | |
| 7 | ABT |
Abbott Laboratories
|
4,269 | $387,369 | |
| 8 | TLSI |
TriSalus Life Sciences, Inc.
|
48,300 | $219,765 |
All Filings in NPCE
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,590,070 | 163,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $828,450 | 63,000 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $972,720 | 63,000 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $649,530 | 63,000 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $701,820 | 63,000 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $36,870 | 3,000 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $33,570 | 3,000 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $20,910 | 3,000 | Shares | Sole | 2024-10-17 | |
| No filing history on record for this holder in this stock. | ||||||